Improving delivery methods for HIV broadly neutralizing antibodies
Vector-Based Delivery of HIV Broadly Neutralizing Antibodies
This study is working on new ways to deliver powerful antibodies that can help fight HIV-1, making them stronger and longer-lasting, so that people at risk of HIV can have better protection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cure Systems LLC NIH-funded |
| Lab location | 1 site (Newton Center, United States) |
| Project ID | NIH-11171844 on NIH RePORTER |
What this research studies
This research focuses on developing advanced methods for delivering broadly neutralizing antibodies (bNAbs) that can effectively combat HIV-1. By engineering next-generation bNAb candidates, the project aims to enhance their potency, increase their presence in body tissues, and extend their effectiveness over time. The research also addresses challenges related to the complex pharmacokinetics of these antibodies and aims to create optimized delivery systems that can improve patient outcomes in HIV prevention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk of HIV infection who may benefit from enhanced preventive measures.
Not a fit: Patients who are already living with HIV and are seeking treatment rather than prevention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with more effective and longer-lasting protection against HIV infection.
How similar studies have performed: Previous research, such as the Antibody Mediated Prevention (AMP) trials, has shown promise in using broadly neutralizing antibodies for HIV prevention, indicating a potential for success in this novel approach.
Where this research is happening
Newton Center, United States
- Cure Systems LLC — Newton Center, United States (Active)
Researchers
- Principal investigator: Miller, Jacqueline — Cure Systems LLC
- Study coordinator: Miller, Jacqueline
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.